Autopsy report · NCT01352702
Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
Cause of deathSlow enrollment, also futility
“Slow recruitment; Study was terminated for futility reasons”
Life of this trial
- Ran for about 3 years before it stopped.
- 46 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Deutsches Herzzentrum Muenchen
- Sponsor type
- University, hospital or other
- Conditions
- Coronary Heart Disease; Atrial Fibrillation; Acute Coronary Syndrome; Atherosclerosis
- Interventions
- Dabigatran; Phenprocoumon
- Participants
- 46
- Sites
- 1
- Countries
- Germany
Trials that died the same way
- Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab
“Study was terminated early because of slow recruitment” - THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
“Study terminated due to slow recruitment.” - Alfuzosin Versus Placebo in Acute Urinary Retention
“The study was early terminated due to slow and difficult recruitment” - A Study of Herceptin (Trastuzumab) in Patients With Metastatic or Advanced Gastric Cancer With Disease Progression
“Study terminated due to slow patient recruitment.” - Nifedipine or Nifedipine Plus Indomethacin for Treatment of Acute Preterm Labor
“Study halted due to slow recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.